Gut microbiota that live in the outer regions
of the mucus and remain a safe distance from epithelial cells provide a
benefit to the
host, but Chassaing and Gewirtz hypothesize that microbiota that encroach upon
host cells drive chronic inflammation that interferes with the
normal action
of insulin, promoting type 2 diabetes.